Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Industry Attractiveness - Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Component
5.1.1 Sensors
5.1.2 Durables
5.2 CGM Device Users
5.2.1 Auckland
5.2.2 New Plymouth
5.2.3 Wellington
5.2.4 Nelson
5.2.5 Canterbury
5.2.6 Otago
5.3 By Provinces
5.3.1 Auckland
5.3.2 New Plymouth
5.3.3 Wellington
5.3.4 Nelson
5.3.5 Canterbury
5.3.6 Otago
5.4 Market Share by Public and Private
5.4.1 Analysis of CGM Devices Distribution Channels (Includes percentage share of Hospitals, clinics, Pharmacies, and other modes)
5.4.2 Analysis of CGM devices prescribers (includes percentage share of Endocrinologists, Diabetologist, and other HCP specialties, and Prescribers knowledge of CGM devices)


6 MARKET INDICATORS
6.1 Type-1 Diabetes Population
6.2 Type-2 Diabetes Population


7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Abbott Diabetes Care
7.1.2 Dexcom Inc.
7.1.3 Medtronic PLC
7.1.4 Eversense
7.2 Company Share Analysis
7.2.1 Abbott Diabetes Care
7.2.2 Dexcom Inc.
7.2.3 Medtronic PLC
7.2.4 Others


8 MARKET OPPORTUNITIES AND FUTURE TRENDS